Hepatitis C is a good news, bad news kind of disease. The bad news is that many with the liver-attacking virus may not even know it. The good news is that once discovered, doctors can effectively treat and even remove it.
Dec 21, 2018
0
1
Hepatitis C virus (HCV) may cause chronic infection to the liver, which can result in irreversible liver damage and liver cancer. How HCV manages to evade the immune system to infect the host chronically is not entirely understood. ...
May 24, 2021
0
20
Despite the fact that hepatitis C virus (HCV) persists chronically in about 80 percent of those infected, some liver cells remain free of the virus even after many years. Now Sung Key Jang of Pohang University of Science ...
Sep 19, 2011
0
0
October is Liver Cancer Awareness Month, which makes this a good time to learn more about risk factors for liver cancer and what you can do to prevent it.
Oct 14, 2023
0
1
The largest population study of hepatitis C in Africa has found three new strains of the virus circulating in the general population in sub-Saharan Africa. The research from the Wellcome Sanger Institute, the MRC-University ...
Dec 17, 2018
0
3
Rutgers University scientists have determined the structure of a hepatitis C surface protein, a finding that could assist in the development of a vaccine to halt the spread of the the deadly disease that has infected 3.2 ...
Feb 19, 2014
0
0
More than 70 million people worldwide are infected with hepatitis C. The disease is treatable, but it is often not recognized. In 80% of cases, it takes chronic courses and can lead to liver damage and even liver cancer. ...
Mar 2, 2022
0
12
A new USC study that zeros in on the workings of individual T cells targeting the hepatitis C virus (HCV) has revealed insights that could assist in the development of an effective vaccine.
Jun 27, 2023
0
2
(HealthDay)—Among patients with hepatitis C virus (HCV) infection and complete response to hepatocellular carcinoma (HCC) treatment, direct-acting antiviral (DAA) therapy is associated with a significant reduction in the ...
Aug 21, 2019
0
3
Health care costs for hepatitis C patients with end-stage liver disease are nearly 2.5 times higher than those in the early stages, according to a Henry Ford Hospital study.
Nov 7, 2011
0
0
